ARCH Venture Fund IX, L.P.

Overview

• HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

ARCH Venture Fund IX, L.P. sits at the top of its group. 9 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (8 companies). Each entity in the chart links to its source.

Filings

1 filings to the SEC since October 2021: 1 other. The latest 1:

1. Feb 24, 2025CORRESP EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

ARCH Venture Fund IX, L.P. has told the SEC it owns more than 5% of 8 companies, latest first (Schedules 13D and 13G).

• Sana BiotechnologySCHEDULE 13G/A Feb 10, 2022 to Aug 14, 2026²
• Lyell Immunopharma, Inc.SCHEDULE 13G/A Feb 14, 2022 to May 15, 2026³
• VIR BiotechnologySCHEDULE 13D/A Jan 10, 2022 to Mar 3, 2026⁴
• Beam TherapeuticsSCHEDULE 13G/A Feb 14, 2022 to May 15, 2025⁵
• Singular Genomics Systems, Inc.SCHEDULE 13G/A Feb 4, 2022 to May 15, 2025⁶
• Boundless Bio (United States)SC 13D Oct 29, 2024⁷
• Gossamer Bio, Inc.SC 13G/A Feb 9, 2024⁸
• Karuna TherapeuticsSC 13D/A Sep 20, 2022⁹